The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study

Table 2

Comparison between the two studied groups according to different genotypes.

	Cancer		Control®		χ^2 (p)		OR (95% CI)
	Observed	Expected	Observed	Expected
HLA-DP rs077A	(n = 40)		(n = 40)
GG	17 (42.5%)	19.6	9 (22.5%)	11.6	6.031 (^MCp = 0.049)	0.059	2.546 (0.964–6.726)
AG	22 (55%)	16.8	25 (62.5%)	19.9		0.496	0.733 (0.300–1.791)
AA	1 (2.5%)	3.6	6 (15%)	8.6		0.081	0.145 (0.017–1.268)
HWE	0.050		0.104
Allele frequency	(n = 80)		(n = 80)
G	56 (70%)		43 (53.8%)		4.478 (0.034)	0.035	2.008 (1.049–3.844)
A	24 (30%)		37 (46.3%)			0.035	0.498 (0.260–0.954)

OR, odds ratio; CI, confidence interval; LL, lower limit; UL, upper limit; ®, reference group; χ², chi-square test; MC, Monte Carlo; HWE, value for Hardy-Weinberg. If , not consistent with HWE. , value for comparing between the studied groups; , value for odds ratio (univariate regression analysis). Statistically significant at .